Discretionary transaction by Smith J.b. of 630000 shares of ABVC Biopharma at 0.75 subject to Rule 16b-3
ABVC Stock | USD 3.20 0.45 16.36% |
About 63% of all ABVC Biopharma's shareholders are looking to take a long position. The analysis of the overall investor sentiment regarding ABVC Biopharma suggests that some traders are interested. The current market sentiment, together with ABVC Biopharma's historical and current headlines, can help investors time the market. In addition, many technical investors use ABVC Biopharma stock news signals to limit their universe of possible portfolio assets.
Filed transaction by ABVC Biopharma Director. Discretionary transaction in accordance with Rule 16b-3
Read at macroaxis.com
Cash Flow Correlation
ABVC Biopharma's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the ABVC Biopharma's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
ABVC Biopharma Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards ABVC Biopharma can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
ABVC Biopharma Fundamental Analysis
We analyze ABVC Biopharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ABVC Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ABVC Biopharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Operating Margin
Operating Margin Comparative Analysis
ABVC Biopharma is currently under evaluation in operating margin category among its peers. Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
ABVC Biopharma Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ABVC Biopharma stock to make a market-neutral strategy. Peer analysis of ABVC Biopharma could also be used in its relative valuation, which is a method of valuing ABVC Biopharma by comparing valuation metrics with similar companies.
Peers
ABVC Biopharma Related Equities
ENSC | Ensysce Biosciences | 4.88 | ||||
KTTA | Pasithea Therapeutics | 1.43 | ||||
RNAZ | Transcode Therapeutics | 0.87 | ||||
RNXT | RenovoRx | 2.42 | ||||
ADIL | Adial Pharmaceuticals | 8.70 |
Complementary Tools for ABVC Stock analysis
When running ABVC Biopharma's price analysis, check to measure ABVC Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABVC Biopharma is operating at the current time. Most of ABVC Biopharma's value examination focuses on studying past and present price action to predict the probability of ABVC Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABVC Biopharma's price. Additionally, you may evaluate how the addition of ABVC Biopharma to your portfolios can decrease your overall portfolio volatility.
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Transaction History View history of all your transactions and understand their impact on performance | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |